MX366651B - Forma a cristalina de (r)-2-((3-(3-aminopiperidin-1-il)-6-metil-5- oxo-1,2,4-triazin-4(5h)-il)metil)-4-fluorobenzonitrilo monobenzoato y método de preparación del mismo y composición farmacéutica que comprende la misma. - Google Patents
Forma a cristalina de (r)-2-((3-(3-aminopiperidin-1-il)-6-metil-5- oxo-1,2,4-triazin-4(5h)-il)metil)-4-fluorobenzonitrilo monobenzoato y método de preparación del mismo y composición farmacéutica que comprende la misma.Info
- Publication number
- MX366651B MX366651B MX2016009667A MX2016009667A MX366651B MX 366651 B MX366651 B MX 366651B MX 2016009667 A MX2016009667 A MX 2016009667A MX 2016009667 A MX2016009667 A MX 2016009667A MX 366651 B MX366651 B MX 366651B
- Authority
- MX
- Mexico
- Prior art keywords
- crystal form
- monobenzoate
- compound
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/08—Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410037009 | 2014-01-24 | ||
| PCT/CN2015/071525 WO2015110077A1 (zh) | 2014-01-24 | 2015-01-26 | 化合物A单苯甲酸盐的晶型α及其制备方法和含有该晶型的药物组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016009667A MX2016009667A (es) | 2017-02-28 |
| MX366651B true MX366651B (es) | 2019-07-17 |
Family
ID=53680849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016009667A MX366651B (es) | 2014-01-24 | 2015-01-26 | Forma a cristalina de (r)-2-((3-(3-aminopiperidin-1-il)-6-metil-5- oxo-1,2,4-triazin-4(5h)-il)metil)-4-fluorobenzonitrilo monobenzoato y método de preparación del mismo y composición farmacéutica que comprende la misma. |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN104803971B (ru) |
| BR (1) | BR112016017087B1 (ru) |
| MX (1) | MX366651B (ru) |
| RU (1) | RU2677660C2 (ru) |
| WO (1) | WO2015110077A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017008684A1 (zh) * | 2015-07-15 | 2017-01-19 | 深圳信立泰药业股份有限公司 | 化合物A的晶型α及其制备方法和含有该晶型的药物组合物 |
| CN106349215B (zh) * | 2015-07-15 | 2022-02-08 | 深圳信立泰药业股份有限公司 | 一种化合物a苯甲酸盐的无定形及其制备方法和含有该无定形的药物组合物 |
| WO2018219295A1 (zh) * | 2017-05-31 | 2018-12-06 | 深圳信立泰药业股份有限公司 | 二肽基肽酶iv抑制剂的氘代1,2,4-三嗪衍生物 |
| CN109692164A (zh) * | 2017-10-20 | 2019-04-30 | 深圳信立泰药业股份有限公司 | 化合物a或其盐的药物组合物及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006068978A2 (en) * | 2004-12-21 | 2006-06-29 | Takeda Pharmaceutial Company Limited | Dipeptidyl peptidase inhibitors |
| TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| CN101360723A (zh) * | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | 制备嘧啶二酮衍生物的方法 |
| TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| FR2933979B1 (fr) * | 2008-07-15 | 2012-08-24 | Pf Medicament | Derives de triazines et uraciles, leur preparation et leur application en therapeutique humaine |
| EP2521721B1 (en) * | 2009-12-30 | 2014-10-01 | Shanghai Fochon Pharmaceutical Co. Ltd | 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors |
| CN103068392A (zh) * | 2010-05-12 | 2013-04-24 | Mapi医药公司 | 苯甲酸阿格列汀的多晶形物 |
| CN103172615A (zh) * | 2013-03-29 | 2013-06-26 | 山东罗欣药业股份有限公司 | 苯甲酸阿格列汀晶型化合物 |
-
2015
- 2015-01-23 CN CN201510033908.7A patent/CN104803971B/zh active Active
- 2015-01-26 WO PCT/CN2015/071525 patent/WO2015110077A1/zh active Application Filing
- 2015-01-26 BR BR112016017087-3A patent/BR112016017087B1/pt active IP Right Grant
- 2015-01-26 MX MX2016009667A patent/MX366651B/es active IP Right Grant
- 2015-01-26 RU RU2016134404A patent/RU2677660C2/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016134404A (ru) | 2018-03-01 |
| BR112016017087A8 (pt) | 2018-04-17 |
| CN104803971B (zh) | 2021-11-30 |
| BR112016017087A2 (pt) | 2017-08-08 |
| CN104803971A (zh) | 2015-07-29 |
| MX2016009667A (es) | 2017-02-28 |
| RU2016134404A3 (ru) | 2018-08-15 |
| RU2677660C2 (ru) | 2019-01-18 |
| BR112016017087B1 (pt) | 2022-12-27 |
| WO2015110077A1 (zh) | 2015-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017004200A (es) | Compuestos de heteroarilo como inhibidores de tirosina-cinasa de bruton (btk) y usos de estos. | |
| AU2015207757A8 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | |
| EP3060041A4 (en) | Prostacyclin compounds, compositions and methods of use thereof | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| MX2019015744A (es) | Composiciones farmaceuticas. | |
| HK1232229A1 (zh) | '- '-硫代核苷的新型化合物及其製備方法、藥物組合物和應用 | |
| MX2018003357A (es) | Proceso de compuesto antifungico. | |
| EP3082819A4 (en) | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | |
| MX2020003139A (es) | Composicion y metodo para ayudar a dormir. | |
| PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
| NZ732402A (en) | Nitrification inhibitor compositions and methods for preparing the same | |
| EA201691363A1 (ru) | Стабилизированные силикатные композиции и их применение в качестве антиперспирантных композиций | |
| PH12017500737B1 (en) | Kcnq2-5 channel activator | |
| EP3232790A4 (en) | Mixotrophic chlorella-based composition, and methods of its preparation and application to plants | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| MX2016012689A (es) | Piridin-2-amidas utiles como agonistas del receptor 2 cannabinoide (cb2). | |
| AU2016204294A1 (en) | Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor | |
| CN106687453A8 (zh) | 作为溴结构域抑制剂的四氢喹啉衍生物 | |
| MX366651B (es) | Forma a cristalina de (r)-2-((3-(3-aminopiperidin-1-il)-6-metil-5- oxo-1,2,4-triazin-4(5h)-il)metil)-4-fluorobenzonitrilo monobenzoato y método de preparación del mismo y composición farmacéutica que comprende la misma. | |
| GEP20196974B (en) | A novel crystalline form of a benzimidazole derivative and a preparation method thereof | |
| GEP20217236B (en) | Composition comprising pentose and polyphenolic compound | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| BR112015031820A2 (pt) | composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos | |
| MX2017007931A (es) | Nuevas formas cristalinas de la sal de monosodio del foramsulfuron. | |
| EP3118207A4 (en) | Inclusion compound of 3',5'-cyclicdiadenylic acid, and method for producing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |